Kingsview Wealth Management LLC trimmed its position in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 20.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,674 shares of the aerospace company’s stock after selling 934 shares during the period. Kingsview Wealth Management LLC’s holdings in Leidos were worth $599,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rakuten Securities Inc. grew its position in Leidos by 1,460.0% in the 3rd quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock valued at $25,000 after buying an additional 146 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in Leidos in the third quarter valued at $29,000. Northwest Investment Counselors LLC acquired a new stake in Leidos in the third quarter valued at $30,000. 1832 Asset Management L.P. acquired a new stake in Leidos in the second quarter valued at $34,000. Finally, Blue Trust Inc. lifted its holdings in Leidos by 251.3% in the second quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock valued at $41,000 after acquiring an additional 201 shares during the period. 76.12% of the stock is currently owned by hedge funds and other institutional investors.
Leidos Trading Down 1.3 %
Leidos stock opened at $164.02 on Thursday. The stock has a market cap of $21.89 billion, a PE ratio of 18.68, a P/E/G ratio of 1.10 and a beta of 0.68. The stock has a 50-day moving average price of $170.97 and a 200 day moving average price of $156.62. Leidos Holdings, Inc. has a 52 week low of $105.52 and a 52 week high of $202.90. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.
Leidos Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be issued a $0.40 dividend. This is a boost from Leidos’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.60 annualized dividend and a yield of 0.98%. Leidos’s payout ratio is 17.31%.
Insider Buying and Selling at Leidos
In other news, Director Noel B. Geer bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The stock was acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the acquisition, the director now owns 2,000 shares of the company’s stock, valued at $322,260. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the sale, the director now owns 20,001 shares of the company’s stock, valued at $3,899,594.97. The trade was a 12.08 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Barclays raised their target price on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, November 4th. TD Cowen raised their target price on Leidos from $175.00 to $200.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Royal Bank of Canada lifted their price target on Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 30th. Truist Financial cut their price target on Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research note on Friday, November 22nd. Finally, The Goldman Sachs Group lifted their price target on Leidos from $205.00 to $228.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $187.77.
Read Our Latest Research Report on Leidos
Leidos Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Read More
- Five stocks we like better than Leidos
- How to Invest in Small Cap Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to invest in marijuana stocks in 7 steps
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOS – Free Report).
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.